5 Turkish Sites DosingAt some point and time the markets will finally wake up and realize that Arch has been dosing at 5 sites for almost 8 months. We have no idea how many patients have been dosed but we know that there has been zero adverse reactions to the dosing. This is huge positive fact.
The other huge factor is they are dosing at 4x times the previous phase 2 dosage, this could produce stellar results.
IMO they have most likely dosed 100+ patients.
Daily volume continues to struggle and now is the time for management to step up and start promoting the story. Management needs to start pounding the payment, spend some $$$ promoting this opportunity and drive new buyers to the market.
There are many aspects out of the control of management but promoting the story is in their control and is their responsibility!
Good luck to all the longs!!